Stem Cell Glycobiology Group, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, UK; Manchester Cancer Research Centre, Division of Molecular & Clinical Cancer Sciences, University of Manchester, UK.
Stem Cell Glycobiology Group, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, UK.
Matrix Biol. 2020 Jan;85-86:15-33. doi: 10.1016/j.matbio.2019.06.009. Epub 2019 Jul 8.
Current materials used for in vitro 3D cell culture are often limited by their poor similarity to human tissue, batch-to-batch variability and complexity of composition and manufacture. Here, we present a "blank slate" culture environment based on a self-assembling peptide gel free from matrix motifs. The gel can be customised by incorporating matrix components selected to match the target tissue, with independent control of mechanical properties. Therefore the matrix components are restricted to those specifically added, or those synthesised by encapsulated cells. The flexible 3D culture platform provides full control over biochemical and physical properties, allowing the impact of biochemical composition and tissue mechanics to be separately evaluated in vitro. Here, we demonstrate that the peptide gels support the growth of a range of cells including human induced pluripotent stem cells and human cancer cell lines. Furthermore, we present proof-of-concept that the peptide gels can be used to build disease-relevant models. Controlling the peptide gelator concentration allows peptide gel stiffness to be matched to normal breast (<1 kPa) or breast tumour tissue (>1 kPa), with higher stiffness favouring the viability of breast cancer cells over normal breast cells. In parallel, the peptide gels may be modified with matrix components relevant to human breast, such as collagen I and hyaluronan. The choice and concentration of these additions affect the size, shape and organisation of breast epithelial cell structures formed in co-culture with fibroblasts. This system therefore provides a means of unravelling the individual influences of matrix, mechanical properties and cell-cell interactions in cancer and other diseases.
目前用于体外 3D 细胞培养的材料通常受到与人体组织相似性差、批次间变异性以及组成和制造复杂性的限制。在这里,我们提出了一种基于无基质基序自组装肽凝胶的“空白板”培养环境。通过掺入与目标组织匹配的基质成分,可以对凝胶进行定制,并且可以独立控制其机械性能。因此,基质成分仅限于特定添加的成分,或通过封装细胞合成的成分。灵活的 3D 培养平台可以完全控制生化和物理特性,允许在体外分别评估生化组成和组织力学的影响。在这里,我们证明了肽凝胶可以支持多种细胞的生长,包括人诱导多能干细胞和人癌细胞系。此外,我们提出了一个概念验证,证明肽凝胶可用于构建与疾病相关的模型。控制肽凝胶剂的浓度可以使肽凝胶的硬度与正常乳腺(<1 kPa)或乳腺肿瘤组织(>1 kPa)相匹配,较高的硬度有利于乳腺癌细胞的存活,而不是正常乳腺细胞。同时,肽凝胶可以用与人类乳腺相关的基质成分(如胶原 I 和透明质酸)进行修饰。这些添加物的选择和浓度会影响与成纤维细胞共培养时形成的乳腺上皮细胞结构的大小、形状和组织。因此,该系统为揭示癌症和其他疾病中基质、机械性能和细胞-细胞相互作用的单独影响提供了一种方法。